谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.
研究兴趣

论文共 335 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
A Phase 2, Open-Label, Safety and Efficacy Study of Telotristat Ethyl Plus First-Line Chemotherapy in Patients with Advanced Biliary Tract Cancer
Richard D. Kim, Nancy Joseph‐Ridge, Jichang Du, Janine North, Cathy Warren,Renuka Iyer
Journal of clinical oncologyno. 3_suppl (2024): 472-472
引用0浏览0引用
0
0
Progress in the Treatment of Anal Cancer: an Overview of the Latest Investigational Drugs
James Yu,Richard D. Kim
Expert Opinion on Investigational Drugsno. 2 (2024): 145-157
引用0浏览0引用
0
0
Abstract CT133: A phase 1b multicenter study of anti-TIM3 (S095018/Sym023) in combination with anti-PD1 (Sym021) in patients with advanced/metastatic recurrent biliary tract cancer
Francois Ghiringhelli,Richard Kim, Teresa Macarulla,Irene Moreno,Albiruni Razak, Jordi Rodon,Chih-Yi Liao,Thomas Marron,Judith Raimbourg, Helene Kaplon, Julia Geromini, Najah Harouki, Christelle Rodrigues, Pauline Darcel, Niels Jorgen Skartved, Rikke Hald, Daleen Lopez-Ravnborg, Peng He, Xenophon Ianopoulos, Vasileios Askoxylakis, Nehal J. Lakhani, Sarah Davis,Amit Mahipal
Cancer Researchno. 7_Supplement (2024)
引用0浏览0引用
0
0
Real-world (RW) Study in Patients (pts) with Metastatic Colorectal Cancer (mcrc) with Long-Term Responses to Regorafenib in the USA
Richard D. Kim, Xiaotian Pan, H. Ostojic, Yiqiao Zhang, Orsolya Lunacsek, Federica Pisa, Marc Peeters
Journal of clinical oncologyno. 3_suppl (2024): 48-48
引用0浏览0引用
0
0
Real-world Use of Pemigatinib for the Treatment of Cholangiocarcinoma in the US
Kim Saverno,Kristin M. Zimmerman Savill, Cherrishe Brown-Bickerstaff, Angele Kotomale, Michael Rodriguez, Bruce Feinberg,Haobo Ren, Mike Blecker,Richard Kim
ONCOLOGIST (2024)
引用0浏览0WOS引用
0
0
Progress in the treatment of anal cancer: an overview of the latest investigational drugs
James Yu,Richard D. Kim
EXPERT OPINION ON INVESTIGATIONAL DRUGSno. 2 (2024): 145-157
引用0浏览0WOS引用
0
0
加载更多
作者统计

#Papers: 331

#Citation: 5200

H-Index: 34

G-Index: 66

Sociability: 7

Diversity: 0

Activity: 5

  • 合作者
  • 学生
  • 导师
暂无相似学者，你可以通过学者研究领域进行搜索筛选
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn